Skip to main content
Top
Published in: Abdominal Radiology 2/2021

01-02-2021 | Magnetic Resonance Imaging | Pancreas

Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis

Authors: Shintaro Ichikawa, Marie-Luise Kromrey, Utaroh Motosugi, Hiroshi Onishi

Published in: Abdominal Radiology | Issue 2/2021

Login to get access

Abstract

Purpose

To compare computed diffusion-weighted imaging (cDWI) feasibility with that of directly acquired DWI for visualizing pancreatic ductal adenocarcinoma (PDAC) and focal autoimmune pancreatitis (AIP).

Methods

From April 2012 to January 2017, 135 patients with PDAC (n = 111) or focal AIP (n = 24) were retrospectively enrolled. They underwent DWI with b-values of 0, 500, and 1000 s/mm2. From DWI0 and DWI1000, we generated cDWIs with targeted b-values of 1500, 2000, and 3000 s/mm2. The lesions’ signal intensities, image quality, signal intensity ratio (SIR) of lesions and pancreatic parenchyma to spinal cord, and lesion-to-pancreatic parenchyma contrast ratio (CR) were compared among the five DWI protocols (DWI500, DWI1000, cDWI1500, cDWI2000, and cDWI3000). SIR was analyzed by receiver operating characteristic (ROC) analyses.

Results

DWI500, DWI1000, and cDWI1500 had higher image quality than cDWI2000 and cDWI3000 (P < 0.001). The incidence of clear hyperintense PDAC was highest on cDWI2000, followed by cDWI1500, and cDWI3000 (P < 0.001–0.002), while the incidence of clear hyperintense AIP was higher on DWI1000, cDWI1500, and cDWI2000 than on DWI500 and cDWI3000 (P = 0.001–0.022). SIRs decreased whereas CRs increased as the b-value increased, for both PDAC and AIP. The area under the ROC curve (AUC) of SIRlesion was significantly lower on cDWI1500 than on cDWI2000 and cDWI3000 (P < 0.001).

Conclusion

cDWI1500 or cDWI2000 generated from b-values of 0 and 1000 s/mm2 were the most effective for visualizing PDAC and focal AIP; however, the SIRlesion AUC was significantly lower on cDWI1500 than on cDWI2000 and cDWI3000.
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://​doi.​org/​10.​3322/​caac.​21492
11.
go back to reference Choi SY, Kim SH, Kang TW, Song KD, Park HJ, Choi YH (2016) Differentiating mass-forming autoimmune pancreatitis from pancreatic ductal adenocarcinoma on the basis of contrast-enhanced MRI and DWI findings. AJR Am J Roentgenol 206:291–300. https://doi.org/10.2214/AJR.15.14974. Choi SY, Kim SH, Kang TW, Song KD, Park HJ, Choi YH (2016) Differentiating mass-forming autoimmune pancreatitis from pancreatic ductal adenocarcinoma on the basis of contrast-enhanced MRI and DWI findings. AJR Am J Roentgenol 206:291–300. https://​doi.​org/​10.​2214/​AJR.​15.​14974.
12.
go back to reference Muhi A, Ichikawa T, Motosugi U, et al (2012) Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging 35:827–836. https://doi.org/10.1002/jmri.22881. Muhi A, Ichikawa T, Motosugi U, et al (2012) Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging 35:827–836. https://​doi.​org/​10.​1002/​jmri.​22881.
15.
go back to reference Kawakami S, Fukasawa M, Shimizu T, et al (2019) Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm. Medicine (Baltimore) 98:e18039. https://doi.org/10.1097/MD.0000000000018039. Kawakami S, Fukasawa M, Shimizu T, et al (2019) Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm. Medicine (Baltimore) 98:e18039. https://​doi.​org/​10.​1097/​MD.​0000000000018039​.
26.
go back to reference Shimosegawa T, Working Group Members of the Japan Pancreas S, Research Committee for Intractable Pancreatic Disease by the Ministry of Labor H, Welfare of J (2012) The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria (ICDC) for autoimmune pancreatitis. Pancreas 41:1341–1342. https://doi.org/10.1097/MPA.0b013e3182706ed5. Shimosegawa T, Working Group Members of the Japan Pancreas S, Research Committee for Intractable Pancreatic Disease by the Ministry of Labor H, Welfare of J (2012) The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria (ICDC) for autoimmune pancreatitis. Pancreas 41:1341–1342. https://​doi.​org/​10.​1097/​MPA.​0b013e3182706ed5​.
Metadata
Title
Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis
Authors
Shintaro Ichikawa
Marie-Luise Kromrey
Utaroh Motosugi
Hiroshi Onishi
Publication date
01-02-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02695-0

Other articles of this Issue 2/2021

Abdominal Radiology 2/2021 Go to the issue